Neuroendocrine Tumors Clinical Trials in Atlanta, Georgia
4 recruitingAtlanta, Georgia
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
Neuroendocrine NeoplasmNeuroendocrine TumorsSST2-positive Neuroendocrine Neoplasms
Crinetics Pharmaceuticals Inc.150 enrolled24 locationsNCT07129252
Recruiting
Phase 3
Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy
Neuroendocrine TumorsGep NetCarcinoid Tumor+4 more
RayzeBio, Inc.338 enrolled54 locationsNCT05477576
Recruiting
Phase 1Phase 2
A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy
Colorectal, CancerGastric CancerNeuroendocrine Tumors
Chimeric Therapeutics135 enrolled4 locationsNCT06055439
Recruiting
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Breast CancerOvarian CancerEndometrial Cancer+40 more
Massive Bio, Inc.50,000 enrolled68 locationsNCT03452774